PathogenDx
PrivateLast Round
Grant
Mar 1, 2021
Total Funding Raised
$12.56M
Company Overview
PathogenDx is a biotechnology company that provides a DNA-based pathogen testing platform for the cannabis, agriculture, food, and human diagnostics industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Environmental Monitoring
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PathogenDx Comparables
Compare PathogenDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TUMI Genomics | 71% | |
| MyFloraDNA, Inc. | 71% | |
| bioMérieux | 69% | |
PathogenDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2021 | ||||
| Grant | Jul 28, 2020 | ||||
| Series B | Sep 30, 2019 | ||||
| Convertible Debt | Jul 17, 2018 |
Key People
Founding team and executive leadership
PathogenDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Salveo Capital | Series B, Convertible Debt |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Altitude Investment Management | Series B, Convertible Debt |
| Flatiron Venture Partners | Series B |
| Advance Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
Announced new product at the International Production & Processing Expo.
- Jan 13, 2026
Launched Unified Salmonella Testing System at IPPE for the poultry industry.
PathogenDx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PathogenDx's valuation, stock price, and market status.